JP2013163662A - Antibody-including pollen allergy protective material - Google Patents
Antibody-including pollen allergy protective material Download PDFInfo
- Publication number
- JP2013163662A JP2013163662A JP2012027387A JP2012027387A JP2013163662A JP 2013163662 A JP2013163662 A JP 2013163662A JP 2012027387 A JP2012027387 A JP 2012027387A JP 2012027387 A JP2012027387 A JP 2012027387A JP 2013163662 A JP2013163662 A JP 2013163662A
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- ostrich
- pollen
- allergen
- protective material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
【課題】アレルギーは、マスト細胞のIgEが抗原であるアレルゲンに結合し、ヒスタミン等を分泌することで生じる。したがって、IgEとアレルゲンとの結合を妨げることでアレルギーの予防が可能であると考えられる。
【解決手段】本発明の抗体含有花粉アレルギー防御素材は、花粉アレルゲンを免疫したダチョウが産卵した卵から得た抗体からなる抗体含有花粉アレルギー防御素材である。また、本発明の抗体含有花粉アレルギー防御素材は、花粉症に自然罹患したダチョウが産卵した卵から得た抗体も含む。
【選択図】なしAllergy is caused by binding of IgE of mast cells to an antigen allergen and secreting histamine and the like. Therefore, it is considered that allergy can be prevented by preventing the binding between IgE and allergen.
The antibody-containing pollen allergy protective material of the present invention is an antibody-containing pollen allergy protective material comprising an antibody obtained from an egg laid by an ostrich immunized with a pollen allergen. The antibody-containing pollen allergy protective material of the present invention also includes an antibody obtained from an egg laid by an ostrich naturally affected with hay fever.
[Selection figure] None
Description
本発明は、ダチョウから得た花粉アレルギーを防御する抗体に関する。 The present invention relates to an antibody that protects against pollen allergy obtained from ostriches.
近年、花粉症は日本を始め世界各国で人を悩ますアレルギー性疾患である。涙、鼻水、クシャミ、咳、発熱、頭痛、けだるさ等、様々な症状を引き起こし、仕事の能率等の低下による経済的ダメージは莫大である。花粉症の原因は、主にスギおよびヒノキの花粉であり、そのなかの特定蛋白質がアレルゲンとされている。スギ花粉のアレルゲンはCryj1、Cryj2であり、ヒノキ花粉のアレルゲンはChao1、Chao2である。実際に、花粉症の患者の血液にはこれらアレルゲンの一つないし複数にたいする抗体が産生されていることが証明されている。 In recent years, hay fever is an allergic disease that affects people all over the world including Japan. It causes various symptoms such as tears, runny nose, sneezing, cough, fever, headache, tediousness, etc., and the economic damage due to the decrease in work efficiency is enormous. The cause of hay fever is mainly pollen of cedar and cypress, and a specific protein among them is considered as an allergen. The allergens of cedar pollen are Cryj1 and Cryj2, and the allergens of cypress pollen are Chao1 and Chao2. In fact, it has been demonstrated that antibodies to one or more of these allergens are produced in the blood of hay fever patients.
従来花粉に対するアレルギーを抑制させる方法として、スギ花粉特異的IgE抗体の産生を抑制する抑制剤は知られていた(特許文献1)。この特許文献では、ヒトの腸内又は発酵食品から分離される細菌を含有させた抑制剤が開示されている。そして、細菌はエンテロコッカス・フェカリスFERM BP−10284(産業技術総合研究所・特許微生物寄託センター寄託番号)であるのが好適であるとされている。 Conventionally, as a method for suppressing allergy to pollen, an inhibitor that suppresses the production of cedar pollen-specific IgE antibody has been known (Patent Document 1). In this patent document, an inhibitor containing bacteria isolated from human intestines or fermented foods is disclosed. And it is said that it is suitable that a bacterium is Enterococcus faecalis FERM BP-10284 (AIST / patent microorganism deposit center deposit number).
アレルギーは、マスト細胞のIgEが抗原であるアレルゲンに結合し、ヒスタミン等を分泌することで生じる。したがって、IgEとアレルゲンとの結合を妨げることでアレルギーの予防が可能であると考えられる。 Allergies are caused by mast cell IgE binding to an antigen allergen and secreting histamine and the like. Therefore, it is considered that allergy can be prevented by preventing the binding between IgE and allergen.
本発明は、体外において花粉アレルゲンと結合することで、花粉アレルゲンがIgEと結合できないようにする抗体をダチョウから得ることで完成した。より具体的には、本発明の抗体含有花粉アレルギー防御素材は、花粉アレルゲンを免疫したダチョウが産卵した卵から得た抗体である。また、本発明の抗体含有花粉アレルギー防御素材は、花粉症に自然罹患したダチョウが産卵した卵から得た抗体も含む。 The present invention has been completed by obtaining an antibody from ostrich that prevents pollen allergens from binding to IgE by binding to pollen allergens outside the body. More specifically, the antibody-containing pollen allergy protective material of the present invention is an antibody obtained from an egg laid by an ostrich immunized with a pollen allergen. The antibody-containing pollen allergy protective material of the present invention also includes an antibody obtained from an egg laid by an ostrich naturally affected with hay fever.
本発明のアレルギー防御素材は、体外において花粉アレルギーのアレルゲンに対して特異的に吸着するので、花粉アレルゲンが体内のIgEに結合することを防止することができる。そのため、アレルギー症状を抑えることができるという効果を奏する。 Since the allergic defense material of the present invention specifically adsorbs to pollen allergens outside the body, the pollen allergen can be prevented from binding to IgE in the body. Therefore, there is an effect that allergic symptoms can be suppressed.
本発明では、花粉症に罹患したダチョウから産卵される卵から抗体を抽出し、上記花粉アレルゲンに対する抗体を大量に回収することに成功し、完成に至った。ダチョウの寿命は60年と驚くほど長く、また開放的な飼育(野外)をするため花粉による感作を受ける確率が高い。そのため、必然的に花粉症になる可能性が高くなると考えられる。 In the present invention, antibodies were extracted from eggs laid by ostrich suffering from hay fever, and a large amount of antibodies against the above-mentioned pollen allergen was successfully recovered and completed. The life of an ostrich is surprisingly long at 60 years, and because of its open breeding (outdoors), there is a high probability of being sensitized by pollen. Therefore, it is considered that the possibility of hay fever inevitably increases.
ダチョウは鳥類であるので、体内で産生された抗体が卵に移行する。つまり、花粉症に自然罹患しているダチョウを用いれば卵から花粉アレルギーに対する抗体が大量に回収できる。ダチョウ一羽から年間400グラム(ウサギ800匹分)の抗体を得ることができる。 Since ostriches are birds, antibodies produced in the body are transferred to eggs. That is, if an ostrich naturally affected with hay fever is used, a large amount of antibodies against pollen allergy can be recovered from the egg. 400 grams of antibody per year (800 rabbits) can be obtained from one ostrich.
その抗体を用いれば、体外で花粉アレルゲンを中和(抗原性を失わせる)することが可能となり、人へのアレルギー性を抑制することができる。これらの抗体は、花粉症予防用のマスクやエアコンフィルター、化粧品、目薬、食品(キャンデーやガム)、口腔洗浄剤、点鼻剤として利用できる。また、スプレーや噴霧剤として空間や壁、衣服の花粉アレルゲンの失活にも応用化できる。 If the antibody is used, it becomes possible to neutralize pollen allergens outside the body (to lose antigenicity), and to suppress allergenicity to humans. These antibodies can be used as hay fever prevention masks, air conditioner filters, cosmetics, eye drops, foods (candy and gum), mouth washes, and nasal drops. It can also be applied to inactivate pollen allergens in spaces, walls and clothes as sprays and sprays.
すなわち、本発明のポイントは、花粉症のダチョウの卵から抗体を得ること、その抗体がヒトの花粉アレルギーを抑制すること、およびスギ花粉のCryj1だけをダチョウに免疫してもCryj2、Chao1、Chao2に交差する抗体が産生されることである。 That is, the point of the present invention is that an antibody is obtained from an egg of a hay fever ostrich, the antibody suppresses human pollen allergy, and even if an ostrich is immunized with only Cryj1 of cedar pollen, Cryj2, Chao1, Chao2 The production of antibodies that cross.
野外飼育のダチョウの血液を採取したところ、15頭中4頭にCryj1、Cryj2、Chao1、Chao2への抗体産生が認められた(ELISA)。それらダチョウから産卵された卵の卵黄より卵黄抗体を精製したところ、Cryj1、Cryj2、Chao1、Chao2に強く反応した(ELISA,Western Blotting)。つまり、花粉症に罹患したダチョウの卵黄には花粉アレルゲンに対する抗体が移行しており、大量に回収されることが可能となった。 When blood of ostriches raised outdoors was collected, antibody production to Cryj1, Cryj2, Chao1, Chao2 was observed in 4 out of 15 animals (ELISA). When the egg yolk antibody was purified from the egg yolk of eggs laid from these ostriches, it reacted strongly with Cryj1, Cryj2, Chao1, Chao2 (ELISA, Western Blotting). In other words, antibodies against pollen allergens have migrated to the egg yolks of ostriches affected by hay fever and can be collected in large quantities.
上記アレルゲンをしみこませた濾紙にダチョウ卵黄抗体を添加し、花粉アレルギー患者(ヒト)の前腕部に塗布した(パッチテスト)ところ、アレルゲン(Cryj1、Cryj2、Chao1、Chao2)のみの濾紙を塗布した場合は、赤発(アレルギー反応)したが、アレルゲンと抗体をしみこませた濾紙では、アレルギー反応が出なかった。つまり、ダチョウ抗体によりヒトの花粉アレルギーが抑制されることが証明された。 When ostrich egg yolk antibody is added to the filter paper impregnated with the allergen and applied to the forearm of a pollen allergic patient (human) (patch test), when filter paper of only allergen (Cryj1, Cryj2, Chao1, Chao2) is applied However, the filter paper impregnated with allergen and antibody did not show any allergic reaction. In other words, it was proved that human pollen allergy is suppressed by the ostrich antibody.
次に人為的にダチョウへアレルゲン(Cryj1)を免疫する場合の結果を示す。初回免疫は、フロイントの完全アジュバントにCryj1 30μgを混和し、メスのダチョウの腰部の筋肉内に接種した。追加免疫は、初回免疫2週間後にフロイントの不完全アジュバントにCryj1 30μgを混和し、同メスダチョウの腰部の筋肉内に接種した。追加免疫2週後以降に産卵されるダチョウ卵より抗体を精製した。 Next, the result of artificially immunizing an ostrich with an allergen (Cryj1) is shown. For the first immunization, 30 μg of Cryj1 was mixed with Freund's complete adjuvant and inoculated into the lumbar muscle of a female ostrich. For booster immunization, 2 weeks after the first immunization, 30 μg of Cryj1 was mixed with Freund's incomplete adjuvant and inoculated into the lumbar muscle of the female ostrich. The antibody was purified from ostrich eggs laid after 2 weeks of booster immunization.
抗体の精製法を以下に示す。卵黄からの抗体(IgY)の精製は以下のように行った。まず、卵黄に5倍量のTBS(20mMTris−HCl、0.15M NaCl、0.5%NaN3)と同量の10%デキストラン硫酸/TBSを加え20分攪拌する。そして1MCaCl2/TBSを卵黄と同量加え攪拌し、12時間静置する。 The antibody purification method is shown below. Purification of antibody (IgY) from egg yolk was performed as follows. First, 5 times the amount of TBS (20 mM Tris-HCl, 0.15 M NaCl, 0.5% NaN 3 ) and the same amount of 10% dextran sulfate / TBS are added to the egg yolk and stirred for 20 minutes. Then, 1MCaCl 2 / TBS is added in the same amount as egg yolk, stirred and allowed to stand for 12 hours.
その後、15000rpmで20分遠心し上清を回収する。次に、最終濃度40%になるように硫酸アンモニウムを加え4℃で12時間静置する。その後、15000rpmで20分遠心し、沈殿物を回収する。最後に、卵黄と同量のTBSに再懸濁し、TBSにて透析する。この課程により90%以上の純度のIgYの回収が可能となった。1個の卵黄より2〜4gのIgYを精製することができた。 Thereafter, the supernatant is recovered by centrifugation at 15000 rpm for 20 minutes. Next, ammonium sulfate is added to a final concentration of 40%, and the mixture is allowed to stand at 4 ° C. for 12 hours. Then, it centrifuges at 15000 rpm for 20 minutes, and collects the precipitate. Finally, it is resuspended in the same amount of TBS as egg yolk and dialyzed with TBS. This process enabled the recovery of 90% or higher purity IgY. 2 to 4 g of IgY could be purified from one egg yolk.
<ELISA法による測定>
以下のELISAにより、得られた抗体の抗原反応性を測定した。2μg/mLのCryj1、Cryj2、Chao1、Chao2をそれぞれELISA用96穴マイクロプレートの各wellに100μl入れ、室温で2時間放置した。その後、PBSで3回洗浄したのち、市販のブロッキング溶液(ブロックエース:大日本住友製薬)を各wellに100μl入れ2時間放置した。その後、PBSで3回洗浄したのち、免疫前および免疫後のダチョウIgY抗体の段階希釈液(2mg/mLを原液として100倍、200倍〜と2倍段階希釈)を各wellに50μl入れ室温で1時間放置した。
<Measurement by ELISA method>
The antigen reactivity of the obtained antibody was measured by the following ELISA. 100 μl of 2 μg / mL of Cryj1, Cryj2, Chao1, and Chao2 was placed in each well of a 96-well microplate for ELISA, and allowed to stand at room temperature for 2 hours. Then, after washing 3 times with PBS, 100 μl of a commercially available blocking solution (Block Ace: Dainippon Sumitomo Pharma Co., Ltd.) was placed in each well and allowed to stand for 2 hours. Then, after washing 3 times with PBS, 50 μl of serial dilutions of ostrich IgY antibody before and after immunization (100 mg, 200-fold and 2-fold serial dilutions using 2 mg / mL as a stock solution) are added to each well at room temperature. Left for 1 hour.
その後、PBSで3回洗浄したのちペルオキシダーゼ標識抗ダチョウIgY・ウサギポリクローナル抗体(自作)を各wellに100μl入れ45分間放置した。PBSで3回洗浄したのち市販のペルオキシダーゼ用発色キット(住友ベークライト)により30分間発色し、ELISA用プレートリーダーにより吸光度(450nm)を測定した。得られた結果を、正常ダチョウ(花粉症に罹患していないダチョウ)のIgY(卵黄抗体)の吸光度値の2倍以上となる最高希釈倍率で示した。結果を表1に示す。 Then, after washing 3 times with PBS, 100 μl of peroxidase-labeled anti-ostrich IgY rabbit polyclonal antibody (self-made) was placed in each well and left for 45 minutes. After washing 3 times with PBS, color was developed for 30 minutes with a commercially available color kit for peroxidase (Sumitomo Bakelite), and the absorbance (450 nm) was measured with an ELISA plate reader. The obtained result was shown by the highest dilution factor which becomes 2 times or more the light absorbency value of IgY (egg yolk antibody) of normal ostrich (ostrich not suffering from pollinosis). The results are shown in Table 1.
野外で飼育されていた雌のダチョウは血液(血清)内にアレルゲン(Cryj1、Cryj2、Chao1、Chao2)に対する抗体を有している。さらに、それら抗体は卵黄にも移行している。Cryj1のみを免疫したダチョウからの血清、卵黄の抗体は、Cryj2、Chao1、Chao2にも交差できる(つまり1アレルゲンを免疫するだけで、スギとヒノキのアレルゲンに交差する抗体が得られる)。 The female ostrich bred outdoors has antibodies against allergens (Cryj1, Cryj2, Chao1, Chao2) in blood (serum). Furthermore, these antibodies have also migrated into the yolk. Serum and egg yolk antibodies from ostrich immunized with Cryj1 alone can also cross Cryj2, Chao1, and Chao2 (ie, immunizing only one allergen yields an antibody that crosses cedar and cypress allergens).
<ウエスタンブロット法>
8%SDS−PAGEによりCryj1、Cryj2、Chao1、Chao2それぞれを20μg電気泳動し、PVDF膜に転写後に、花粉症ダチョウ(No.1)の卵黄より得た抗体(1000倍希釈)を1時間室温で反応させた。界面活性剤入りPBSで洗浄後、HRP標識抗ダチョウIgYウサギ抗体を1時間室温で反応させた。PBSで洗浄後、ECLキットによりレントゲンフィルムにて可視化した。結果を図1に示す。花粉症ダチョウの卵黄から回収した抗体は、スギ花粉およびヒノキ花粉に強く反応することがわかる。
<Western blot method>
20 μg each of Cryj1, Cryj2, Chao1, and Chao2 was electrophoresed by 8% SDS-PAGE, transferred to a PVDF membrane, and then an antibody (1000-fold diluted) obtained from the egg yolk of hay fever ostrich (No. 1) was used for 1 hour at room temperature. Reacted. After washing with PBS containing a surfactant, HRP-labeled anti-ostrich IgY rabbit antibody was reacted at room temperature for 1 hour. After washing with PBS, it was visualized with an X-ray film using an ECL kit. The results are shown in FIG. It can be seen that the antibody recovered from the egg yolk of hay fever ostrich reacts strongly with cedar pollen and cypress pollen.
<ダチョウ抗体の花粉アレルギーに対する効果(パッチテスト)>
直径7mmの円形濾紙にスギアレルゲン(Cryj1:20μgとCryj2:20μg)をしみこませたものを、花粉アレルギー患者ボランティア26人の前腕部皮膚に塗布した。上記、アレルゲン含有濾紙にダチョウ抗体(花粉症罹患ダチョウ(No.1)の卵黄から得た卵黄抗体20μg)を添加させたものを、同人物の前腕部皮膚の別箇所に塗布した。また、対照として、PBSのみをしみこませた濾紙を同人物の前腕部皮膚の別箇所に塗布した。24時間後の濾紙塗布部分の発赤の程度を観察した。表2にその結果を示す。
<Effect of ostrich antibody on pollen allergy (patch test)>
A soy allergen (Cryj1: 20 μg and Cryj2: 20 μg) soaked in a circular filter paper having a diameter of 7 mm was applied to the forearm skin of 26 volunteers with pollen allergy. The above-mentioned allergen-containing filter paper added with an ostrich antibody (20 μg of egg yolk antibody obtained from the egg yolk of hay fever-affected ostrich (No. 1)) was applied to another part of the forearm skin of the same person. In addition, as a control, a filter paper soaked with PBS alone was applied to another part of the person's forearm skin. The degree of redness of the coated part of the filter paper after 24 hours was observed. Table 2 shows the results.
スギ花粉抗原だけをしみこませた場合は、26人中24人にダチョウの抗体を添加場合は、被験者26人のうち24人に発赤が確認されたが、ダチョウの抗体を添加した場合は、3名に発赤が確認されただけであった。 When only cedar pollen antigen was impregnated, 24 out of 26 ostrich antibodies were added, and 24 out of 26 subjects were confirmed to be red, but when ostrich antibody was added, 3 The name was only reddish.
図2には、上記のものを同人物の前腕部皮膚の別箇所に塗布した場合の1時間後の写真を示す。ダチョウ抗体を添加することでスギ花粉に対するアレルギー反応(発赤)が抑制された。絆創膏の後は、3か所ともに残っている。 FIG. 2 shows a photograph after 1 hour when the above is applied to another part of the forearm skin of the same person. Allergic reaction (redness) to cedar pollen was suppressed by adding ostrich antibody. After the bandage, all three remain.
その抗体を用いれば、体外で花粉アレルゲンを中和(抗原性を失わせる)することが可能となり、人へのアレルギー性を抑制することができる。これらの抗体は、花粉症予防用のマスクやエアコンフィルター、化粧品、目薬、食品(キャンデーやガム)、口腔洗浄剤、点鼻剤として利用できる。また、スプレーや噴霧剤として空間や壁、衣服の花粉アレルゲンの失活にも応用化できる。 If the antibody is used, it becomes possible to neutralize pollen allergens outside the body (to lose antigenicity), and to suppress allergenicity to humans. These antibodies can be used as hay fever prevention masks, air conditioner filters, cosmetics, eye drops, foods (candy and gum), mouth washes, and nasal drops. It can also be applied to inactivate pollen allergens in spaces, walls and clothes as sprays and sprays.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012027387A JP6200630B2 (en) | 2012-02-10 | 2012-02-10 | Pharmaceutical composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012027387A JP6200630B2 (en) | 2012-02-10 | 2012-02-10 | Pharmaceutical composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013163662A true JP2013163662A (en) | 2013-08-22 |
| JP6200630B2 JP6200630B2 (en) | 2017-09-20 |
Family
ID=49175265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012027387A Active JP6200630B2 (en) | 2012-02-10 | 2012-02-10 | Pharmaceutical composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6200630B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015105266A (en) * | 2013-12-02 | 2015-06-08 | オーストリッチファーマ株式会社 | ALLERGEN ANTIBODY, COMPOSITION HAVING THE SAME AND FILTER HAVING ANTIBODY |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62215534A (en) * | 1985-11-25 | 1987-09-22 | Fuoobesuto Kk | Specific antibody-containing material from egg, its production and use |
| JPH08502163A (en) * | 1992-09-01 | 1996-03-12 | イミュロジック ファーマスーティカル コーポレイション | Allergenic proteins and peptides derived from cedar pollen |
| JPH09511747A (en) * | 1994-04-08 | 1997-11-25 | イミユロジク・フアーマシユーチカル・コーポレーシヨン | Pharmaceutical composition for treating cedar pollen allergy |
| JP2005077191A (en) * | 2003-08-29 | 2005-03-24 | Akita Prefecture | Simple cryj1 immunoassay related to selection of low-allergen japanese cedar |
| JP2006195718A (en) * | 2005-01-13 | 2006-07-27 | Fujitsu Ltd | Electronic device, input processing control method, and program therefor |
| JP2008169142A (en) * | 2007-01-11 | 2008-07-24 | Osaka Prefecture Univ | Production method of antibody against food poisoning bacteria |
| JP2009023985A (en) * | 2007-01-11 | 2009-02-05 | Osaka Prefecture Univ | Method for producing antibody against influenza virus |
| JP2010013361A (en) * | 2008-07-01 | 2010-01-21 | Ostrich Pharma Kk | Antibody for norovirus, and method for producing the same |
| JP2010014637A (en) * | 2008-07-07 | 2010-01-21 | Fujifilm Corp | Detection method of interaction between molecule using fret method in gas phase and harmful substance depleting agent |
| JP2010037226A (en) * | 2008-08-01 | 2010-02-18 | Fujifilm Corp | Harmful substance-removing material, and method for removing harmful substance |
| JP2011020927A (en) * | 2009-07-13 | 2011-02-03 | Ostrich Pharma Kk | Antibody produced from ostrich and filter using the same |
-
2012
- 2012-02-10 JP JP2012027387A patent/JP6200630B2/en active Active
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62215534A (en) * | 1985-11-25 | 1987-09-22 | Fuoobesuto Kk | Specific antibody-containing material from egg, its production and use |
| JPH08502163A (en) * | 1992-09-01 | 1996-03-12 | イミュロジック ファーマスーティカル コーポレイション | Allergenic proteins and peptides derived from cedar pollen |
| JPH09511747A (en) * | 1994-04-08 | 1997-11-25 | イミユロジク・フアーマシユーチカル・コーポレーシヨン | Pharmaceutical composition for treating cedar pollen allergy |
| JP2005077191A (en) * | 2003-08-29 | 2005-03-24 | Akita Prefecture | Simple cryj1 immunoassay related to selection of low-allergen japanese cedar |
| JP2006195718A (en) * | 2005-01-13 | 2006-07-27 | Fujitsu Ltd | Electronic device, input processing control method, and program therefor |
| JP2008169142A (en) * | 2007-01-11 | 2008-07-24 | Osaka Prefecture Univ | Production method of antibody against food poisoning bacteria |
| JP2009023985A (en) * | 2007-01-11 | 2009-02-05 | Osaka Prefecture Univ | Method for producing antibody against influenza virus |
| JP2010013361A (en) * | 2008-07-01 | 2010-01-21 | Ostrich Pharma Kk | Antibody for norovirus, and method for producing the same |
| JP2010014637A (en) * | 2008-07-07 | 2010-01-21 | Fujifilm Corp | Detection method of interaction between molecule using fret method in gas phase and harmful substance depleting agent |
| JP2010037226A (en) * | 2008-08-01 | 2010-02-18 | Fujifilm Corp | Harmful substance-removing material, and method for removing harmful substance |
| JP2011020927A (en) * | 2009-07-13 | 2011-02-03 | Ostrich Pharma Kk | Antibody produced from ostrich and filter using the same |
Non-Patent Citations (1)
| Title |
|---|
| "きゃんパる:インタビュー・会いたい人 京都府立大学大学院教授・塚本康浩さん", 毎日新聞 夕刊, vol. 第4頁, JPN6015046414, 2 April 2010 (2010-04-02), ISSN: 0003616099 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015105266A (en) * | 2013-12-02 | 2015-06-08 | オーストリッチファーマ株式会社 | ALLERGEN ANTIBODY, COMPOSITION HAVING THE SAME AND FILTER HAVING ANTIBODY |
Also Published As
| Publication number | Publication date |
|---|---|
| JP6200630B2 (en) | 2017-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6830462B2 (en) | Antibodies and antibody-containing compositions | |
| Twaroch et al. | Mold allergens in respiratory allergy: from structure to therapy | |
| Sampson | Food allergy: past, present and future | |
| Jeong et al. | Standardization of house dust mite extracts in Korea | |
| Sircar et al. | Epitope mapping of rhi o 1 and generation of a hypoallergenic variant | |
| Jeong et al. | Cross-reactivity between oak and birch pollens in Korean tree pollinosis | |
| Moreno et al. | Orthologous allergens and diagnostic utility of major allergen Alt a 1 | |
| Campana et al. | Hypoallergenic derivatives of the major birch pollen allergen Bet v 1 obtained by rational sequence reassembly | |
| Biagioni et al. | Migrants and allergy: a new view of the atopic march | |
| JP6200630B2 (en) | Pharmaceutical composition | |
| Porcaro et al. | Anaphylaxis to cutaneous exposure to bovine colostrum based cream | |
| Li et al. | Hypoallergenic derivatives of Scylla paramamosain heat-stable allergens alleviated food allergy symptoms in Balb/c mice | |
| Jeong et al. | The effects of storage conditions on the stability of house dust mite extracts | |
| Chen et al. | Clinical response to subcutaneous Dermatophagoides pteronyssinus immunotherapy in children with allergic rhinitis and asthma is independent of sensitization to Blomia tropicalis allergens | |
| JP2011020927A (en) | Antibody produced from ostrich and filter using the same | |
| Daengsuwan et al. | Allergen sensitization to aeroallergens including Blomia tropicalis among adult and childhood asthmatics in Thailand. | |
| CN101115504A (en) | Controlling minor allergens to improve safety of immunotherapy | |
| Wang et al. | The conformational epitope of Ara h 5 was crucial to the severe reactivity of peanut allergy | |
| AT503297B1 (en) | Use of antibody or its derivative for preparation of medicament for passive immunization of individual for preventing and/or treating allergic reactions in individual caused by exposure to birch pollen allergen | |
| US20230141616A1 (en) | Method for establishing epicutaneously sensitized food allergy animal model | |
| JPWO2019093137A1 (en) | A method of preventing the acquisition of allergic predisposition in infancy through the inhibitory effect of IgE class-specific immune response | |
| WO2010089671A2 (en) | Contiguous overlapping peptides for treatment of birch pollen allergy | |
| ES2634241T3 (en) | New wheat allergens | |
| Yun et al. | Comparison of allergenic components between German cockroach whole body and fecal extracts | |
| Tourdot et al. | Evaluation of therapeutic sublingual vaccines in a murine model of chronic house dust mite allergic airway inflammation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150122 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20151117 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160113 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160531 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20161122 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20170123 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170321 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170808 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170828 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6200630 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |